Kelly Schick
Net worth: 475 827 $ as of 2026-05-30
Net worth: 475 827 $ as of 2026-05-30
Kelly A. Schick is Vice President-Account Management at ScripNet LLC since 2012.
Ms. Schick is Chief People Officer at C4 Therapeutics, Inc. since 2021.
Former roles include Head-Global Talent at Bristol Myers Squibb Co. and Chief Human Resources Officer & Senior VP at AMAG Pharmaceuticals, Inc. Education includes undergraduate studies at Boston University and graduate studies at The Curtis L.
Carlson School of Management.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-13 | 108,885 ( 0.1% ) | 475 827 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| C4 THERAPEUTICS, INC. | Human Resources Officer | 2021-01-11 |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Corporate Officer/Principal | - |
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| AMAG PHARMACEUTICALS, INC. | Human Resources Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Bristol Myers Squibb Co.
Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ScripNet LLC
ScripNet LLC Data Processing ServicesTechnology Services Provides pharmacy benefit management electronic processing services | Technology Services |
AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Curtis L. Carlson School of Management
The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4 Therapeutics, Inc.
C4 Therapeutics, Inc. BiotechnologyHealth Technology Develops targeted protein degradation therapeutics for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions